Pandemic influenza: Vaccine manufacturers are now actively producing H1N1 pandemic specific vaccine. The WHO SAGE committee has advised that vaccination strategy should focus on protecting the integrity
of national healthcare systems and so has prioritized healthcare workers. Prioritization will be especially relevant if initial supplies are limited.
Using currently available information regarding the expected profile, possible allocation of H1N1 specific vaccine and
predictions of pandemic severity, VacZine Analytics has modelled a potential vaccine demand scenario in the United States.
The provided model and presentation also give indications of potential cumulative revenue (for vaccine
manufacturers) and required antigen amounts (approximation) for a full vaccination campaign.
THIS PRODUCT IS A SUMMARY PRESENTATION + MODEL
*Prices quotes are for 1 region license only. Regions are North America, or EU or ROW.
For UK orders VAT will be added at 15.0%.
Please review the TERMS and CONDITIONS of purchase.
